文献速递乳腺US

对25-39岁女性中超声灰阶和剪切波弹性成像表现良性而推定纤维腺瘤者免除活检策略的审核

Audit of eliminating biopsy for presumed fibroadenomas with benign ultrasound greyscale and shear-wave elastography findings in women aged 25-39 years.
PubMed 文献 · Clin Radiol · 2020-08-26

本研究评估了对25-39岁女性中临床及超声灰阶提示良性、剪切波弹性成像平均硬度<50 kPa的推定纤维腺瘤不予活检策略的安全性。76例女性平均随访2年,3例(4%)经第二放射科医生复核影像后召回活检,2例在同侧乳房不同位置发生乳腺癌;作者认为该策略可能安全且可接受。

要点

  • 对25-39岁女性超声灰阶及剪切波弹性成像(平均硬度<50 kPa)表现良性的推定纤维腺瘤,可考虑免除活检和随访。
  • 第二放射科医生复核存档超声图像可召回影像表现并非 definitively 良性者,本研究中召回3例(4%)。
  • 随访期间2例在同侧乳房不同位置发生乳腺癌,与评估的良性病变位置不同。

关键影像表现/征象

  • 超声灰阶表现提示良性肿块,剪切波弹性成像平均硬度<50 kPa。
  • 第二放射科医生复核图像后召回3例(4%)患者。
  • 随访中5例(7%)因同一肿块再次就诊,3例(4%)因不同良性问题再次就诊。
  • 2例在同侧乳房不同位置发生乳腺癌,与评估的良性病变位置不同。

诊断标准与关键数值

  • 入选标准为临床和超声灰阶表现提示良性肿块,且剪切波弹性成像平均硬度<50 kPa。
  • 最短随访12个月,平均随访2年。

临床应用与阅片要点

  • 作者认为,对25-39岁女性中临床良性、超声灰阶表现良性且剪切波硬度<50 kPa的肿块不予活检或随访的策略可能安全且可接受。
  • 由第二放射科医生复核存档超声图像,可将影像表现并非 definitively 良性者召回活检。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To assess the safety of a policy of not biopsying presumed fibroadenomas with benign ultrasound and shear-wave elastography findings in women aged 25-39 years.

MATERIALS AND METHODS: Patients aged 25-39 years were included after attending a one-stop clinic before 01/05/2019 where clinical and ultrasound greyscale findings suggested a benign mass and shear-wave elastography showed a mean stiffness of <50 kPa. Such patients were reassured and discharged without biopsy or follow-up. The archived ultrasound images were reviewed subsequently by a second radiologist who could recall patients for biopsy if he deemed the imaging findings to be not definitively benign. Local and national electronic records were reviewed to identify whether these patients later re-presented with breast problems.

RESULTS: Seventy-six women with a mean age of 33 years were included. The minimum follow-up was 12 months and the mean follow-up was 2 years. Three (4%) of patients were recalled after review of the ultrasound images by a second radiologist. Five (7%) patients re-presented with the same lump. Three (4%) patients re-presented with a different benign problem. Two patients presented with breast cancer in the ipsilateral breast but at a different location from the assessed benign lesion.

CONCLUSION: Early audit results of a policy of not biopsying or following up clinically benign masses with benign ultrasound greyscale appearances and shear wave stiffness <50 kPa in women aged 25-39 years suggest that this approach may be safe and acceptable.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Evans A, Sim YT, Lawson B, et al. Audit of eliminating biopsy for presumed fibroadenomas with benign ultrasound greyscale and shear-wave elastography findings in women aged 25-39 years. Clin Radiol. 2020. PMID: 32861462. doi:10.1016/j.crad.2020.08.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。